Exploring Injective: A Comprehensive Analysis of INJ
In this detailed analysis of Injective, we'll cover all the essential information about the company.
Headquarters: New York
Year Founded: 2018
Founders: Eric Chen and Albert
Chone
Native Token : INJ
Total Funding: $56.7 million
The Main Features of Injective Are:
-->CosmWasm Compatibility
-->Bridge
-->Staking
-->Burn Auction
-->Insurance Funds
Injective enables developers to create advanced applications through its pre-built modules, functioning as an open and interoperable smart contracts platform across multiple chains.
Injective leverages the Cosmos SDK and the Tendermint proof-of-stake consensus framework to ensure rapid transaction finality and seamless cross-chain transactions across major Layer-1 networks such as Ethereum and Cosmos Hub.
Injective focuses on user experience, offering efficient capital allocation tools and decentralized financial market access, with backing from significant crypto players like Binance.
Who Founded Injective?
Eric Chen and Albert Chon are the co-founders of Injective. Today, Chen is the CEO and Chon is the chief technology officer.
Interoperability
You can use the Injective Bridge to transfer assets in and out of Injective with the following blockchains:
Ethereum
Solana
Cosmos Hub
Osmosis
Evmos
Axelar
Moonbeam
Secret Network
STAKING
Injective operates on a proof-of-stake model with an APR of 15.98%, and more than $400 million worth of$INJ has been staked
BURN AUCTION
Burn Auctions on Injective incentivize exchanges to contribute to the platform, with the winning bidder receiving the trading fees collected for the week and contributing to the deflationary pressure on the INJ token supply.
INSURANCE FUNDS
Insurance Funds on Injective serve to cover deficits resulting from bankrupt positions during high volatility in margin trading, ensuring stability within the trading environment.
